Phase II Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Recurrent Glioblastoma
Phase of Trial: Phase II
Latest Information Update: 21 Nov 2017
At a glance
- Drugs Dianhydrogalactitol (Primary) ; Lomustine
- Indications Glioblastoma
- Focus Therapeutic Use
- Sponsors Del Mar Pharmaceuticals
- 21 Nov 2017 According to a DelMar Pharmaceuticals media release, interim results from the study have been presented at the 22nd Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO).
- 21 Nov 2017 Interim results published in a DelMar Pharmaceuticals media release.
- 06 Sep 2017 According to a DelMar Pharmaceuticals media release, update from the study will be presented at the 19th Annual Rodman & Renshaw Global Investment Conference 2017.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History